quinuclidines has been researched along with Esophageal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doki, Y; Eguchi, H; Kobayashi, T; Kurokawa, Y; Makino, T; Morii, E; Nakajima, K; Saito, T; Takahashi, T; Tanaka, K; Yamasaki, M; Yamashita, K | 1 |
| Azar, WJ; Clemons, NJ; Cullinane, C; Duong, CP; Fennell, CM; Haupt, S; Haupt, Y; Liu, DS; Montgomery, KG; Phillips, WA; Read, M; Wiman, KG | 1 |
| Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Sasaki, T; Tanabe, S; Wada, T; Yano, T | 1 |
| Chow, WH; Finkle, WD; Frankl, H; Fraumeni, JF; McLaughlin, JK; Ziel, HK | 1 |
1 trial(s) available for quinuclidines and Esophageal Neoplasms
| Article | Year |
|---|---|
Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Cross-Over Studies; Dexamethasone; Esophageal Neoplasms; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Stomach Neoplasms; Vomiting | 2016 |
3 other study(ies) available for quinuclidines and Esophageal Neoplasms
| Article | Year |
|---|---|
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.
Topics: Animals; Apoptosis; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Mice; Mutation, Missense; Proto-Oncogene Proteins c-bcl-2; Quinuclidines; Reactive Oxygen Species; Signal Transduction; Tumor Protein p73; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Mice; Mice, Knockout; Mutation; Neoplasms, Experimental; Quinuclidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2015 |
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
Topics: Adenocarcinoma; Aged; Cardia; Case-Control Studies; Causality; Chlordiazepoxide; Cholinergic Antagonists; Drug Combinations; Esophageal Diseases; Esophageal Neoplasms; Esophagitis; Gastroesophageal Reflux; Hernia, Hiatal; Histamine H2 Antagonists; Humans; Logistic Models; Middle Aged; Quinuclidines; Risk Factors; Stomach Neoplasms | 1995 |